Connect Biopharma is trading 5.01% higher at $0.92 on October 9, 2026, in line with a biotech-sector rally.
- Biotech is rallying, with XBI up 2.50%, amid strong IPO debuts and deal activity; broader indexes are also higher, with gains below 0.5%.
- No company-specific announcement was listed October 9; positive Phase 2 COPD results announced September 30 are not a new catalyst for this move.
- No trading-volume figure is available in the provided price context.